Get startedLog in
    Picture of POINT Biopharma Global logo

    PNT — POINT Biopharma Global News Story

    0.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeMid Cap
    All News

    Brief: Point Biopharma Global Completes Randomization In PNT2002’S Phase 3 Splash Trial

    Picture of POINT Biopharma Global logoPOINT Biopharma Global
    12/01/2023 13:52
    Jan 12 (Reuters) - POINT Biopharma Global Inc  PNT.O :
    * POINT BIOPHARMA COMPLETES RANDOMIZATION IN PNT2002’S PHASE
3
SPLASH TRIAL

Source text for Eikon:  ID:nGNX65nbY6 
Further company coverage:  LNTH.O 
 ((reuters.briefs@thomsonreuters.com;))

    Recent news on POINT Biopharma Global

    See all news